Remdesivir is a drug in clinical trials showing promise in reducing the severity of COVID-19 in those infected.
It was recently approved by the U.S. FDA, and the government has said it's distributing the promising coronavirus drug to the hardest-hit areas of the country. Eventually, all 50 states will get it.
We take a closer look at Remdesivir and its prospects as a longterm solution to the coronavirus.Guests
- UC Davis School of Veterinary Medicine Distinguished Professor Emeritus Dr. Niels Pedersen